San Diego, CA, United States of America

Michael Schwaebe

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 154(Granted Patents)


Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Michael Schwaebe: Innovator in Pharmaceutical Patents

Introduction: Michael Schwaebe, a prominent inventor based in San Diego, CA, has made significant contributions to the pharmaceutical industry through his innovative work. With a total of 19 patents to his name, Schwaebe is recognized for developing groundbreaking compounds and methods that advance medical science.

Latest Patents: Among Schwaebe's latest patents are "Quinolone analogs and methods related thereto," which introduce novel quinolone compounds capable of inhibiting cell proliferation and inducing cell apoptosis. The invention also includes methods for preparing these compounds and pharmaceutical compositions. Another notable patent is for "Polymorphs and salts of a kinase inhibitor," which pertains to new crystalline polymorphic salt forms of a specific compound that holds promise for treating conditions mediated by casein kinase (CK) and poly(ADP-ribose) polymerase (PARP).

Career Highlights: Michael Schwaebe has built a remarkable career, having worked with leading companies such as Cylene Pharmaceuticals, Inc. and Senhwa Biosciences, Inc. His work focuses on creating innovative solutions in drug development and treatment options.

Collaborations: Throughout his career, Schwaebe has collaborated with notable colleagues, including Jeffrey Paul Whitten and Fabrice Pierre. These partnerships have enhanced the research and development processes, leading to numerous advancements in the field.

Conclusion: Michael Schwaebe's contributions to the innovation of pharmaceutical patents highlight his role as an influential inventor in the industry. His dedication to developing effective compounds and methods continues to drive progress in medical research, ultimately benefiting patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…